FNY Investment Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History

FNY Investment Advisers’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-540	Closed	-$50K	–	1027
2021 Q4	$50K	Buy	+540	New	+$35.6K	0.03%	251
2021 Q1	–	Sell	-17,500	Closed	-$1.34M	–	1113
2020 Q4	$1.34M	Buy	+17,500	New	+$1.31M	0.37%	63
2019 Q3	–	Sell	-277	Closed	-$16K	–	1261
2019 Q2	$16K	Buy	+277	New	+$14.3K	﹤0.01%	513

FNY Investment Advisers's ARNA Position: Q1 2022 in Review

FNY Investment Advisers sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 540 shares — an estimated $50K sold.

FNY Investment Advisers first reported a position in ARNA in Q2 2019 and held it in 3 quarters. The position peaked at $1.34M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

FNY Investment Advisers reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
FNY Investment Advisers sold 540 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $50K.
FNY Investment Advisers first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 3 quarters.
FNY Investment Advisers's Arena Pharmaceuticals Inc position peaked at $1.34M in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on FNY Investment Advisers's 13F filing for Q1 2022, filed 25 Apr 2022.